Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

mHealth fysisk aktivitetsintervention for unge kræftoverlevere (AYA-PACT)

22. september 2026 opdateret af: AHS Cancer Control Alberta

Unge og unge voksne bliver fysisk aktive efter kræftforsøget

In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.

Studieoversigt

Status

Aktiv, ikke rekrutterende

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Background:

There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis.

Aim:

Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors.

Methods:

The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

287

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Alberta
      • Calgary, Alberta, Canada, T2N5G2
        • Arthur J.E. Child Comprehensive Cancer Centre

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

15 år til 39 år (Barn, Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Lives in Alberta
  • Diagnosed with invasive malignancy in Alberta
  • Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences
  • Have the ability to read, write and speak English
  • Have access to the Internet on at least a weekly basis
  • Have a mobile phone with a text messaging plan
  • Willing to be randomized to either arm.

Exclusion Criteria:

  • Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q)
  • Currently pregnant or planning to become pregnant within the next 6 months
  • Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: mHealth Physical Activity Intervention

The intervention arm will receive a 12 month mobile health (mHealth) physical activity intervention with a goal of increasing their moderate-vigorous intensity physical activity levels by 90 minutes per week above baseline.

The intervention includes a physical activity prescription, a Polar activity tracker watch, access to a private AYA cancer survivor community through the Polar Flow community platform, mHealth nudges and surveys via text messaging, and regular phone or email contact from study staff.

Ingen indgriben: Control

Controls received "standard of care" from their medical team and were not provided with any physical activity guidance.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Changes in weekly minutes of moderate-vigorous intensity physical activity
Tidsramme: Baseline to 12 months

Measured by ActiGraph

Baseline to 12 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Changes in weekly minutes of moderate-vigorous intensity physical activity
Tidsramme: Baseline to 6 months and 24 months.

Measured by ActiGraph

Baseline to 6 months and 24 months.
Changes in weekly minutes of sleep
Tidsramme: Baseline, 6 months, 12 months, 24 months

Measured by ActiGraph

Baseline, 6 months, 12 months, 24 months
Changes in weekly minutes of sedentary time
Tidsramme: Baseline, 6 months,12 months, 24 months

Measured by ActiGraph

Baseline, 6 months,12 months, 24 months
Changes in moderate-vigorous physical activity using the self-administered Past Year Total Physical Activity Questionnaire (PYTPAQ).
Tidsramme: Baseline, 12 months, 24 months.

Met-Hours per week and hours per week of moderate-vigorous physical activity

Baseline, 12 months, 24 months.
Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality Score
Tidsramme: Baseline, 6 months,12 months

Global score range is 0 to 23 where higher scores indicate worse sleep quality

Baseline, 6 months,12 months
Changes in weight
Tidsramme: Baseline, 6 months,12 months

Measured in kilograms

Baseline, 6 months,12 months
Changes in body mass index (BMI)
Tidsramme: Baseline, 6 months,12 months

Measured by combining height (meters) and weight (kilograms) and reported in kg/m2

Baseline, 6 months,12 months
Changes in waist and hip circumference
Tidsramme: Baseline, 6 months,12 months

Measured in centimeters

Baseline, 6 months,12 months
Changes in cardiorespiratory fitness
Tidsramme: Baseline, 6 months,12 months

Measured by peak oxygen consumption in relative (ml/kg/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation

Baseline, 6 months,12 months
Changes in cardiorespiratory fitness
Tidsramme: Baseline, 6 months,12 months

Measured by peak oxygen consumption in absolute (L/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation

Baseline, 6 months,12 months
Changes in grip strength
Tidsramme: Baseline, 6 months,12 months

Measured in kilograms using a hand dynamometer

Baseline, 6 months,12 months
Changes in upper body muscular strength
Tidsramme: Baseline, 6 months,12 months

Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM

Baseline, 6 months,12 months
Changes in upper body muscular endurance
Tidsramme: Baseline, 6 months,12 months

Measured in kilograms using the maximum number of chest press repetitions completed at 50% of estimated 1-RM

Baseline, 6 months,12 months
Changes in lower body muscular strength
Tidsramme: Baseline, 6 months,12 months

Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM

Baseline, 6 months,12 months
Changes in lower body muscular endurance
Tidsramme: Baseline, 6 months,12 months

Measured in kilograms using the maximum number of leg press repetitions completed at 70% of estimated 1-RM

Baseline, 6 months,12 months
Changes in frailty
Tidsramme: Baseline, 6 months,12 months

Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Mental Health Component subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better mental health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Physical Health Component subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better physical health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Physical Functioning subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Role-physical subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Bodily Pain subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate less pain

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) General Health subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better health

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Vitality subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher vitality

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Social Functioning subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 (SF-36) Role-emotional subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate higher functioning

Baseline, 6 months,12 months
Changes in the Short Form 36 Mental Health subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 100 where higher scores indicate better mental health

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscale
Tidsramme: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Physical subscale
Tidsramme: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Emotional subscale
Tidsramme: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Cognitive subscale
Tidsramme: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Cancer Distress Scales for AYAs Cancer Worry subscale
Tidsramme: Baseline, 6 months,12 months

Scores range from 0 to 100 where higher scores indicate more distress

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 72. Higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 16 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 36 where higher scores indicate poorer cognition

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscale
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 16 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F)
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 52 where higher scores indicate better quality of life.

Baseline, 6 months,12 months
Changes in the Comprehensive Score for Financial Toxicity (COST)
Tidsramme: Baseline, 6 months,12 months

Score range is from 0 to 44 where higher scores indicate better financial wellbeing

Baseline, 6 months,12 months
Changes in fear of cancer recurrence - short form (FCRI-SF)
Tidsramme: Baseline, 6 months, 12 months

Score range is from 0 - 36 where higher scores indicate greater fear of recurrence severity.

Baseline, 6 months, 12 months
Changes in Sedentary Behaviour using a 7 day Sedentary Recall
Tidsramme: Baseline, 6 months, 12 months.

Hours of sitting during the week and on weekends for the following categories: (1) traveling to work, (2) at work or school, (3) watching television, (4) using a computer, and (5) leisure time not including television.

Baseline, 6 months, 12 months.
Changes in environmental barriers that prevent or limit walking and cycling where a person lives or works - PANES Questionnaire
Tidsramme: Baseline, 6 months, 12 months.

Score range is from 1 to 4 with higher values indicating greater environmental support for physical activity.

Baseline, 6 months, 12 months.
Changes in Exercise Self-Efficacy - Subscale (FITNET Questionnaire)
Tidsramme: Baseline, 6 months, 12 months

Range of scores from 11 to 55 with higher scores indicated higher self-efficacy.

Baseline, 6 months, 12 months
Changes in Social Support from Family and Friends related to Exercise - Subscale (FITNET Questionnaire)
Tidsramme: Baseline, 6 months, 12 months.

Range of scores from 10 to 50 with higher scores indicating more support.

Baseline, 6 months, 12 months.
Changes in Self-Monitoring related to setting exercise goals and planning exercise activities - Subscale (FITNET Questionnaire)
Tidsramme: Baseline, 6 months, 12 months.

Range of scores from 12 to 60 with higher scores indicating more self-monitoring.

Baseline, 6 months, 12 months.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Efterforskere

  • Studieleder: Christine Friedenreich, Cancer Care Alberta
  • Ledende efterforsker: Miranda Fidler-Benaoudia, Cancer Care Alberta

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

27. september 2021

Primær færdiggørelse (Faktiske)

16. juli 2026

Studieafslutning (Anslået)

1. maj 2027

Datoer for studieregistrering

Først indsendt

9. februar 2021

Først indsendt, der opfyldte QC-kriterier

19. februar 2021

Først opslået (Faktiske)

21. februar 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

25. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

22. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner